Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
History
Citation
Ramakrishna, R., Diamond, T. H., Alexander, W., Manoharan, A. & Golombick, T. (2020). Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy. Clinical Case Reports, 8 (4), 739-744.